Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma. Hemasphere. 2025 Jul; 9(7):e70178.